Choosing Wisely
Finish the question, "Do I really blank?"
Do I really need this test or procedure?
Question 1. What is the inheritance pattern shared by both xeroderma pigmentosum (XP) and Cockayne syndrome (CS)?
A. Autosomal dominant with variable penetrance
B. X-linked recessive
C. Autosomal recessive
D. Mitochondrial inheritance
E. Autosomal dominant with anticipation
Answer: C. Both XP and CS are inherited in an autosomal recessive pattern, requiring biallelic pathogenic variants (one from each parent) for disease manifestation. Parents are obligate heterozygous carriers who are typically asymptomatic.
1. What is the primary function of a eukaryotic promoter?
A. To terminate transcription
B. To recruit the transcription machinery and determine where transcription begins
C. To remove introns from pre-mRNA
D. To transport mRNA out of the nucleus
B
Jenny has an XPB/ERCC3 mutation affecting TFIIH and currently shows severe photosensitivity and early freckling but normal development. Which future finding would most strongly suggest that she has developed features of combined xeroderma pigmentosum–Cockayne syndrome rather than xeroderma pigmentosum alone?
A. Development of multiple UV-induced skin cancers
B. Progressive developmental delay, growth failure, and neurologic deterioration
C. Continued freckling in sun-exposed areas
D. Vitamin D deficiency caused by strict sun avoidance
E. Additional episodes of severe sunburn
B. Progressive developmental delay, growth failure, and neurologic deterioration
A child is not yet using any words besides "mama" and "dada" at 15 months. Based on the CDC framework, what should a caregiver understand about this milestone checklist?
A) It confirms the child has a language delay requiring immediate therapy
B) It is a diagnostic tool that should be used to determine eligibility for early intervention services
C) It is a communication tool meant to prompt a conversation with the doctor and consideration of screening, not a diagnosis
D) It means the child has lost a skill they previously had
Answer: C — CDC explicitly states these checklists are not diagnostic or screening tools themselves; they're meant to flag concerns for follow-up discussion and, if needed, referral to formal screening.
Finish the question, "Are blank?"
Are there simpler, safer options?
Question 2. A couple who are both carriers of a pathogenic variant in the same XP gene are planning a pregnancy. What is the probability that their child will be affected?
A. 50%
B. 75%
C. 100%
D. 25%
E. 12.5%
Answer: D. In autosomal recessive inheritance, when both parents are carriers, each pregnancy carries a 25% risk of an affected child, a 50% chance of a carrier, and a 25% chance of an unaffected non-carrier.
Explain the nomenclature of “c.296T>C”
Human Genome Variation Society (HGVS) standard:
It shows that a specific DNA change happens at the coding level (c.), where the nucleotide thymine (T) at position 296 is replaced by cytosine (C)
what is the role of vitamin d in the body?
Vitamin D helps your body absorb calcium, build strong bones, and support your immune system
At what age does the CDC recommend a child's first general developmental screening, according to AAP guidelines?
A) 6 months
B) 9 months
C) 12 months
D) 18 months
Answer: B — 9 months is when CDC's milestone checklist specifically notes it's "time for developmental screening," per AAP recommendations.
Finish the question, " What happens blank?"
What happens if I don't do anything?
Question 3. Approximately how many genes can harbor biallelic mutations to cause xeroderma pigmentosum?
A. 2
B. 4
C. 8
D. 12
E. 15
Answer: C. XP can result from biallelic mutations in any of eight genes — seven nucleotide excision repair (NER) pathway genes (XPA, XPB/ERCC3, XPC, XPD/ERCC2, XPE/DDB2, XPF/ERCC4, XPG/ERCC5) and one translesion synthesis gene (POLH, causing XP-variant).
A cell is preparing to transcribe a protein-coding gene. Which sequence most accurately describes normal eukaryotic transcription initiation?
A. RNA polymerase III binds a TATA box at the end of the gene, forms a spliceosome, and synthesizes RNA in the 3′ → 5′ direction.
B. TATA-binding protein, a component of TFIID, may recognize a TATA box within the core promoter near the transcription start site. RNA polymerase II and the general transcription factors then assemble into a preinitiation complex. TFIIH unwinds the promoter DNA and phosphorylates RNA polymerase II, allowing it to begin synthesizing RNA in the 5′ → 3′ direction.
C. DNA polymerase binds a CAAT box within the protein-coding sequence. TFIIA unwinds the DNA, after which translation begins in the nucleus.
D. RNA polymerase I binds the poly(A) tail of a newly formed mRNA. TFIIH then forms a replication fork and converts the DNA directly into protein.
B
Genetic testing reveals a pathogenic mutation in XPB (ERCC3), which encodes a component of TFIIH. Which molecular abnormality most directly explains this patient’s extreme sensitivity to sunlight?
A. Failure to repair double-strand breaks through homologous recombination
B. Failure to correct replication errors through mismatch repair
C. Failure to remove UV-induced pyrimidine dimers through nucleotide excision repair
D. Failure to repair uracil residues through base-excision repair
E. Failure to join DNA ends through nonhomologous end joining
Correct answer: C. Failure to remove UV-induced pyrimidine dimers through nucleotide excision repair
Explanation: UV radiation produces bulky DNA lesions, especially cyclobutane pyrimidine dimers. These lesions are normally removed by nucleotide excision repair. XPB is part of TFIIH, which helps unwind DNA around the damaged region so the lesion can be excised and replaced.
A rural county has one primary care physician for every 3,500 residents, compared to a national average of one per 1,200. The county has offered competitive salaries and signing bonuses for three years with little success in recruiting permanent physicians. Which of the following approaches is best supported by workforce research as a long-term solution to this shortage?
A) Continue increasing salary incentives until recruitment targets are met
B) Recruit internationally trained physicians on temporary visas to fill positions
C) Prioritize admission and training pipelines for students from rural backgrounds who are more likely to return to practice there
D) Consolidate services by closing the local clinic and redirecting patients to the nearest regional hospital
Answer: C — rural-origin students are consistently the strongest predictor of long-term rural retention; salary incentives alone have a well-documented track record of failing to produce durable placement.
Finish this question, " What are blank?"
What are the risks?
Question 5. Which of the following statements about the genetic basis of Cockayne syndrome is correct?
A. CS is caused exclusively by mutations in ERCC8 (CSA)
B. ERCC6 (CSB) mutations account for approximately 70% of CS cases, while ERCC8 (CSA) accounts for approximately 30%
C. CS and XP never share causative genes
D. Mutations in ERCC6 and ERCC8 always produce the same clinical phenotype regardless of the specific variant
E. CS follows X-linked recessive inheritance
Answer: B. CS is caused by biallelic mutations in one of two principal genes: ERCC6 (CSB), which accounts for ~70% of cases, and ERCC8 (CSA), which accounts for ~30%. Notably, mutations in these same genes can also cause UV-sensitive syndrome (UVSS), a much milder condition — demonstrating that different mutations within the same gene can produce vastly different clinical outcomes. Additionally, certain genes such as ERCC2/XPD and ERCC5/XPG can cause both XP and CS overlap phenotypes.
Give a no more than two sentence summary on normal transcription initiation and the role of the promoter in eukaryotes
Example:
Transcription begins when transcription factors bind a gene’s promoter and recruit RNA polymerase II.
The promoter is a DNA region near the gene that acts like an “on switch and starting line”—it tells RNA polymerase where to begin and helps control how much RNA is made.
Explain how variable expressivity is shown in this case
The NER disorders exemplify how variable expressivity arises not simply from modifier genes or environment, but from the position-specific functional impact of mutations within a multifunctional protein complex. The same gene can produce cancer-prone (XP), developmental (TTD), or neurodegenerative (CS) phenotypes depending on whether the mutation primarily disrupts DNA repair, transcription, or both.
A 68-year-old woman with heart failure lives 90 miles from the nearest cardiologist and has missed her last three follow-up appointments because she has no reliable transportation and cannot afford to miss a full day of work for each visit. Her rural clinic has broadband internet access and a nurse on-site. Which intervention would most directly and sustainably address the specific barrier described in this case?
A) Provide a one-time transportation voucher for her next scheduled visit
B) Refer her to a closer clinic that does not have a cardiologist on staff
C) Establish a telehealth partnership so she can have video follow-up visits with the cardiologist from her local clinic
D) Encourage her to switch to a primary care physician for her heart failure management instead
Answer: C — this directly removes the transportation/distance barrier for ongoing follow-up (not just a single visit like A), preserves access to appropriate specialist-level care (unlike B and D), and uses infrastructure already in place at her local clinic.
Finish the question, "How blank?"
How much does it cost?
Jenny's family lives in Jonesville, an isolated farming community that Dr. Jameson notes deviates from Hardy-Weinberg assumptions due to a high rate of consanguineous marriage. Suppose local health records show the following for Jonesville:
(a) Calculate the 10-year cumulative incidence of XP in Jonesville, expressed per 1,000 live births.
(b) Calculate the prevalence of XP in Jonesville today, expressed per 1,000 total population.
(a) Incidence:
Incidence = (new cases ÷ population at risk over the time period) × 1,000
= (3 ÷ 400) × 1,000
= 7.5 per 1,000 live births
(b) Prevalence:
Prevalence = (existing cases ÷ total population) × 1,000
= (4 ÷ 4,000) × 1,000
= 1 per 1,000 population
Explain how the c.296T>C mutation resulted in Jenny having XP?
in short: T→C at position 296 → Phe99Ser substitution → partially impaired XPB helicase activity within TFIIH → reduced (not absent) NER capacity → accumulation of unrepaired UV-induced DNA lesions → the clinical XP phenotype Jenny presents with
At Jenny's 17-month visit, Dr. Myers notes that at her prior visit (some months earlier) she had achieved normal developmental milestones as outlined by the CDC, and later Dr. Otey emphasizes that her continued normal development is "very encouraging" but must be watched closely going forward.
Based on the case, why does Jenny's developmental history matter clinically — what is Dr. Otey specifically watching for by tracking her milestones over time?
A) To confirm the diagnosis of Xeroderma pigmentosum itself, since developmental delay is a core diagnostic feature of XP
B) To monitor for a shift toward Cockayne syndrome, since the same XPB/TFIIH mutation can cause either XP alone or a combined XP-Cockayne phenotype, and developmental delay (from TFIIH's transcription role, not its repair role) is a hallmark of Cockayne involvement
C) To rule out trichothiodystrophy, since developmental delay is how that condition is distinguished from XP
D) To assess for vitamin D deficiency, since delayed motor milestones would suggest inadequate cholecalciferol supplementation
The case explicitly ties this together — TFIIH has two separable functions (DNA repair and transcription initiation), and the XPB mutation's variable expressivity means Jenny could have XP alone (repair defect) or XP combined with Cockayne syndrome (added transcription defect). Cockayne syndrome's clinical hallmark is developmental delay/failure to thrive, which is why normal CDC milestone achievement is reassuring but not conclusive — it has to be reassessed at every visit, since the transcription-repair distinction is exactly what separates a purely dermatologic risk (skin cancer surveillance) from a neurodevelopmental one.
Describe the major barriers to healthcare access in rural or isolated communities, and propose at least two potential solutions for each barrier category you identify (e.g., workforce, geographic, financial, technological, or cultural barriers). Which solution do you think would have the greatest impact, and why?
great!